Patents Represented by Attorney Bret E. Bozicevic & Reed LLP Field
  • Patent number: 5885540
    Abstract: Methods for producing a room temperature stable, phase pure .alpha.-C.sub.3 P product, and compositions derived therefrom, are provided. In the subject method, a tricalcium phosphate source is heated to a temperature sufficient to convert substantially all of said tricalcium phosphate source to a substantially phase pure .alpha.-C.sub.3 P product. The temperature of the resultant product is rapidly cooled to a temperature below about 700.degree. C., resulting in a room temperature stable, reactive .alpha.-C.sub.3 P product. The resultant .alpha.-C.sub.3 P product may be milled to provide an .alpha.-C.sub.3 P composition which may find use in the preparation of calcium phosphate cements.
    Type: Grant
    Filed: July 1, 1997
    Date of Patent: March 23, 1999
    Assignee: Norian Corporation
    Inventors: Mark Fulmer, Brent R. Constantz, Ira C. Ison, Bryan M. Barr
  • Patent number: 5876936
    Abstract: Methods of enzymatic nucleic acid sequencing are provided in which solid-phase capturable chain terminators are employed. In the subject methods, sequencing fragments are generated, where the fragments comprise capturable chain terminators. The fragments are then captured on a solid phase and separated from the remaining components of the sequencing reaction. The fragments are then released from the solid phase, size separated and detected to yield sequencing data from which the sequence of the nucleic acid is determined.
    Type: Grant
    Filed: January 15, 1997
    Date of Patent: March 2, 1999
    Assignee: Incyte Pharmaceuticals, Inc.
    Inventor: Jingyue Ju
  • Patent number: 5858685
    Abstract: Benign prostatic hyperplasia-prostate specific antigen (BPH-PSA) and methods for its preparation are provided. Also provided are antibodies specific for BPH-PSA, and methods of their use in immunoassays for detecting the presence of BPH-PSA in a sample. The subject immunoassays find use in diagnosing the conditions associated with elevated serum PSA levels, such as prostate cancer and BPH.
    Type: Grant
    Filed: March 21, 1997
    Date of Patent: January 12, 1999
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Thomas A. Stamey, Zuxiong Chen, John E. McNeal
  • Patent number: 5846312
    Abstract: Two component, storage stable apatitic cement compositions, as well as methods for their production, are provided. The dry component of subject apatitic cements comprises basic calcium source particles at least partially coated with a partially neutralized acidic calcium phosphate. The dry component of subject compositions is prepared by combining basic calcium source particles with dissolved acidic phosphate in at least a partially aqueous medium, whereby the basic calcium source particles become partially coated with a partially neutralized acidic calcium phosphate. The reaction is terminated prior to completion of the reaction between the acidic phosphate and the basic calcium source by removing the available water from the reaction mixture. In a first mode, the subject cement may be produced by mechanically mixing an acidic phosphate source with basic calcium source particles in the presence of an aqueous solvent and stopping the reaction between the acid and base prior to completion.
    Type: Grant
    Filed: July 1, 1997
    Date of Patent: December 8, 1998
    Assignee: Norian Corporation
    Inventors: Ira C. Ison, Mark T. Fulmer, Bryan M. Barr, Brent R. Constantz